On August 11, 2023, Better Therapeutics, Inc. closed the transaction. The transaction included participation from 10 investors. The company has paid sales commissions of $126,900 in the transaction.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0122 USD | +11.74% | +4.27% | -93.74% |
21/03 | Better Therapeutics, Inc. Receives Notice of Default from Hercules Capital, Inc | CI |
20/03 | Better Therapeutics, Inc.(NasdaqCM:BTTX) dropped from S&P TMI Index | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-93.74% | 7L | |
+26.37% | 4.82TCr | |
-1.01% | 4.17TCr | |
+43.45% | 4.1TCr | |
-5.31% | 2.88TCr | |
+9.34% | 2.56TCr | |
-21.69% | 1.9TCr | |
+6.23% | 1.29TCr | |
+26.99% | 1.2TCr | |
-3.38% | 1.18TCr |
- Stock Market
- Equities
- BTTX Stock
- News Better Therapeutics, Inc.
- Better Therapeutics, Inc. announced that it has received $2.115287 million in funding